Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EGFRviii Protein (APC,His tag)

EGFRv3 Origin: Human Host: HEK-293 Cells Recombinant
Catalog No. ABIN7271625
  • Target See all EGFRviii (EGFRv3) products
    EGFRviii (EGFRv3) (EGFR vIII (EGFRv3))
    Protein Type
    Recombinant
    Origin
    Human
    Source
    • 9
    HEK-293 Cells
    Purification tag / Conjugate
    This EGFRviii protein is labelled with APC,His tag.
    Purpose
    APC-Labeled Human EGFRvIII Protein, His Tag (Site-specific conjugation)
    Sequence
    Leu 25 - Ser 378
    Characteristics
    APC-Labeled Human EGFRvIII, His Tag (EGI-HA2H8) is produced via conjugation of APC to Human EGFRvIII, His Tag with a new generation site-specific technology under optimal conditions with a proprietary technology. Human EGFRvIII, His Tag is expressed from human 293 cells (HEK293). It contains AA Leu 25 - Ser 378 (Accession # NP_001333870.1).
  • Application Notes
    This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 42.4 kDa.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, 0.5 % BSA, pH 7.4
    Storage
    -20 °C
    Storage Comment
    -20°C, avoid light
  • Target
    EGFRviii (EGFRv3) (EGFR vIII (EGFRv3))
    Alternative Name
    EGFRvIII (EGFRv3 Products)
    Background
    Synonyms:EGFRvIII,Description:The epidermal growth factor receptor (EGFR, ErbB-1, HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer. The type III EGF deletion-mutant receptor (EGFRvIII) is the most common mutation and was first identified in primary human glioblastoma tumors, EGFR gene amplification is correlated with the structural rearrangement of the gene. The EGFRvIII gene has an in-frame deletion of 801 base pairs, corresponding to exons 2-7 in the mRNA, resulting in the deletion of amino acids 30-297 in the extracellular domain and the generation of a glycine at the fusion point
    Molecular Weight
    42.4 kDa
    NCBI Accession
    NP_001333870
You are here: